| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | NEUTRAL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.74▲ | 4.73▲ | 4.72▲ | 4.85▼ | 4.52▲ |
| MA10 | 4.74▲ | 4.70▲ | 4.74▲ | 4.77▼ | 4.42▲ |
| MA20 | 4.72▲ | 4.75▲ | 4.83▼ | 4.61▲ | 4.11▲ |
| MA50 | 4.74▲ | 4.85▼ | 4.79▼ | 4.45▲ | 3.34▲ |
| MA100 | 4.82▼ | 4.78▼ | 4.68▲ | 4.09▲ | 2.72▲ |
| MA200 | 4.87▼ | 4.66▲ | 4.60▲ | 3.44▲ | 2.02▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | 0.008▲ | -0.015▼ | 0.017▲ | 0.011▲ |
| RSI | 58.377▲ | 47.204▼ | 44.547▼ | 55.191▲ | 66.787▲ |
| STOCH | 68.855 | 71.630 | 26.198 | 73.509 | 58.982 |
| WILL %R | 0.000▲ | -23.333▲ | -70.513 | -39.474 | -25.781 |
| CCI | 54.545 | 60.364 | -38.525 | 20.436 | 134.907▲ |
|
Tuesday, November 04, 2025 05:12 AM
Comprehensive meeting with FDA conducted in Q3 in conjunction with Breakthrough Therapy Designation Key aspects of a potential NDA application discussed and aligned with the Agency Praxis plans to ...
|
|
Monday, November 03, 2025 06:23 AM
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that data from the ongoing Phase 1b study of R2891, a ...
|
|
Thursday, October 23, 2025 06:08 AM
Tango Therapeutics (NASDAQ:TNGX) added ~15% in the premarket on Thursday after the oncology-focused biotech announced an early-stage trial readout for its anticancer agent vopimetostat (TNG462) in ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/11/25 | 4.75 | 4.775 | 4.62 | 4.75 | 310,800 |
| 06/11/25 | 4.92 | 5.05 | 4.73 | 4.76 | 333,800 |
| 05/11/25 | 4.82 | 4.98 | 4.7867 | 4.95 | 318,707 |
| 04/11/25 | 4.89 | 4.965 | 4.77 | 4.86 | 367,600 |
| 03/11/25 | 4.76 | 4.95 | 4.702 | 4.91 | 389,900 |
| 31/10/25 | 4.51 | 4.83 | 4.51 | 4.78 | 213,900 |
| 30/10/25 | 4.55 | 4.80 | 4.51 | 4.56 | 337,700 |
| 29/10/25 | 4.68 | 4.82 | 4.52 | 4.58 | 259,500 |
| 28/10/25 | 4.85 | 4.936 | 4.69 | 4.73 | 384,200 |
| 27/10/25 | 4.47 | 4.90 | 4.47 | 4.84 | 486,900 |
|
|
||||
|
|
||||
|
|